Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - Growth
Category: Index Fund
Launch Date: 26-04-2024
AUM:
₹ 160.07 Cr
Expense Ratio
1.11%
Benchmark
NIFTY 100 Equal Weight TRI
ISIN
INF277KA1BD0
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
1. Nitin Sharma, 2. Rakesh Prajapati
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - Growth | 6.78 | - | - |
| NIFTY 100 Equal Weight TRI | 10.01 | 18.18 | 20.91 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
12.8944
Last change
0.02 (0.1644%)
Fund Size (AUM)
₹ 160.07 Cr
Performance
17.31% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns
Fund Manager
1. Nitin Sharma, 2. Rakesh Prajapati
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| FORTIS HEALTHCARE LIMITED. EQ | 9.94 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 8.86 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 6.91 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 5.94 |
| ALKEM LABORATORIES LIMITED EQ | 5.78 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 5.31 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 5.03 |
| BIOCON LIMITED EQ | 4.17 |
| Krishna Institute Of Medical Sciences Limited | 3.31 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.29 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 100.08 |